Evidence map›Paper›PMID 41648009›Full record

ReviewFrontiers in microbiology2025

Multidrug-resistant

Bo Yan, Can Yan, Yafang Ding, Siyi Cai, Yujin Wang, Elvis Agbo, Xianyun Xu, Kunhao Qin, Qiang Fu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Beyond Resistance Genes:Life (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Haloalkalitolerant Nitrile-UtilizingInternational journal of microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bo Yan *Affiliated Hospital of Jinggangshan University, Ji'an, China.
Can Yan *Affiliated Hospital of Jinggangshan University, Ji'an, China.
Yafang Ding *Affiliated Hospital of Jinggangshan University, Ji'an, China.
Siyi CaiAffiliated Hospital of Jinggangshan University, Ji'an, China.
Yujin WangAffiliated Hospital of Jinggangshan University, Ji'an, China.
Elvis AgboJiangxi Province Key Laboratory of Organ Development and Epigenetics, Clinical Medical Research Center, Affiliated Hospital of Jinggangshan University, Medical Department of Jinggangshan University, Ji'an, China.
Xianyun XuDepartment of Clinical Laboratory, Ji'an Central People's Hospital, Ji'an, China.
Kunhao QinAffiliated Hospital of Jinggangshan University, Ji'an, China.
Qiang FuAffiliated Hospital of Jinggangshan University, Ji'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of drug-resistant bacterial infections has profoundly impacted global public health. Key pathogens include multidrug-resistant

Indexed as

antimicrobial resistancebacteriophageinfectionsMDR-PAtherapy

Identifiers

PMID41648009
PMCPMC12869996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.